Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Pulmonary Fibrosis

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Pulmonary Fibrosis in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's2 (33.33)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fu, XM; Hu, ZW; Li, K; Li, Z; Lv, Q; Lv, XX; Wang, XX; Wang, ZY1
At Muhammed, R; El-Medany, A; El-Medany, G; El-Rakhawy, FI; Hagar, HH; Moursi, M1
Alberton, M; Andres, G; Brentjens, J; Camussi, G; Pawlowski, I; Roffinello, C; Tetta, C1
Ambrosio, G; Carratù, L; De Marino, V; Faraone, S; Marone, G; Sofia, M; Triggiani, M1
Ishii, Y; Kitamura, S; Kobayashi, J1
Arnoux, B; Duarte, G; Fonseca, E; Mendes, AC; Teles de Araújo, A1

Other Studies

6 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Pulmonary Fibrosis

ArticleYear
Rupatadine protects against pulmonary fibrosis by attenuating PAF-mediated senescence in rodents.
    PloS one, 2013, Volume: 8, Issue:7

    Topics: Animals; Cellular Senescence; Cyproheptadine; Lung; Male; Mice; Mice, Inbred C57BL; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Tumor Suppressor Protein p53

2013
Attenuation of bleomycin-induced lung fibrosis in rats by mesna.
    European journal of pharmacology, 2005, Feb-10, Volume: 509, Issue:1

    Topics: Animals; Bleomycin; Drug Administration Schedule; Drug Screening Assays, Antitumor; Glutathione; Hydroxyproline; Injections, Intraperitoneal; Lung; Male; Mesna; Nitric Oxide Synthase; Peptidyl-Dipeptidase A; Peroxidase; Platelet Activating Factor; Pulmonary Fibrosis; Rats; Rats, Wistar; Time Factors; Tumor Necrosis Factor-alpha; Weight Gain; Weight Loss

2005
Acute lung inflammation induced in the rabbit by local instillation of 1-0-octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine or of native platelet-activating factor.
    The American journal of pathology, 1983, Volume: 112, Issue:1

    Topics: Acute Disease; Animals; Bronchi; Complement C5; Complement C5a; Complement C5a, des-Arginine; Female; Histocytochemistry; Immunochemistry; Injections; Lung; Macrophages; Male; Platelet Activating Factor; Pneumonia; Pulmonary Alveoli; Pulmonary Fibrosis; Rabbits

1983
Characterization of platelet-activating factor acetylhydrolase in human bronchoalveolar lavage.
    American journal of respiratory and critical care medicine, 1997, Volume: 156, Issue:1

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Aged; Asthma; Bronchoalveolar Lavage Fluid; Female; Humans; Lung; Male; Middle Aged; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Pulmonary Fibrosis; Reference Values

1997
[Roles of arachidonic acid cascade and related substances in respiratory diseases].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1991, Sep-10, Volume: 80, Issue:9

    Topics: Animals; Arachidonic Acid; Asthma; Bronchi; Humans; Lung Diseases; Macrophages; Muscle Tonus; Platelet Activating Factor; Pulmonary Fibrosis; Respiratory Tract Diseases; Sarcoidosis; Smoking

1991
Surfactant modifications and lipidic mediators in occupational lung diseases.
    Sarcoidosis, 1989, Volume: 6 Suppl 1

    Topics: Blood-Air Barrier; Bronchoalveolar Lavage Fluid; Humans; Lipids; Platelet Activating Factor; Pulmonary Fibrosis; Pulmonary Surfactants

1989